Investing.com -- The beauty industry faces a sluggish start to 2025, but companies remain hopeful for a gradual recovery later in the year.
Several major beauty multinationals, including L'Oréal (EPA:OREP), Coty (NYSE:COTY), Estée Lauder and Elf Beauty, have reported weak calendar fourth-quarter results, triggering negative share price reactions. The industry’s growth slowed sharply in the second half of 2024, dropping to 3.5% from 5.5% in the first half, with all regions and categories, except fragrance, experiencing a downturn.
UBS noted that the start of 2025 has shown no major improvement, with Q1 expected to mirror the softness of Q4. Asia Travel Retail is forecast to contract further, while Mainland China remains in slight decline. In North America, makeup is under pressure, and dermocosmetics are slowing, though fragrance remains a bright spot.
UBS warned that expectations for a quick turnaround in Q2 may be overly optimistic, as hopes rest on easier year-on-year comparisons, potential inventory rebuilding in North America, and new product launches. The bank also flagged rising costs as a persistent challenge for the industry.
Beiersdorf (ETR:BEIG), which reports earnings on Feb. 27, could feel the impact of weak demand in Asia and the U.S. UBS expects its consumer division to post 7.8% organic sales growth in Q4 but sees downside risks to its 2025 outlook, forecasting 5.1% growth versus consensus expectations of 6%.